Saxenda is a brand name for the medicine liraglutide, used for ongoing weight management. In Australia, it's approved for eligible adults, and some teenagers, as part of a broader plan that also includes a reduced-calorie diet and more physical activity. A doctor decides whether it's suitable after considering a person's body mass index (BMI), other health conditions, current medicines, and their treatment goals.
Liraglutide belongs to a class of medicines called GLP-1 receptor agonists, GLP-1 being a hormone the body releases after eating. It works similarly to this hormone, helping manage appetite and the feeling of fullness. It's given as a daily injection, usually starting at a low dose that's gradually increased to reduce side effects.
Common side effects include nausea, vomiting, diarrhoea, constipation and stomach discomfort. More serious side effects are possible, and it isn't suitable for everyone, so regular follow-up appointments let the doctor check progress and decide whether continuing treatment is still the right choice.
Book a telehealth consultation with an AHPRA-registered GP for assessment, prescriptions, referrals or advice.
Book ConsultationSaxenda is a once-daily injectable weight-loss medicine containing liraglutide, prescribed alongside diet and exercise changes.
No. This glossary explains general health terminology, not your individual symptoms or test results. Speak with a qualified health professional for advice about your circumstances. For a medical emergency, call 000.
Proudly Australian-owned and operated